Characterization of ALT elevations during the 5-year GENEr8-1 trial of valoctocogene roxaparvovec gene transfer for severe hemophilia A

Feb 6, 2026 — 09:51 am - 10:00 AM
The Auditorium

Main session
Presenter:
Robert KLAMROTH